Abstract 157: The Association Between Serum Magnesium Levels and Qt Interval Duration During Therapeutic Hypothermia and its Effects on Neurological Outcomes
Introduction: Sudden cardiac arrest is a major cause of mortality in the United States and globally. Therapeutic hypothermia (TH) has demonstrated success in improving neurological outcomes in post-cardiac arrest patients. TH causes several physiologic ECG changes, including QTc prolongation. TH also decreases serum magnesium levels. These changes may lead to malignant ventricular arrhythmia and poor neurological outcome. We aimed to evaluate the association between the QTc interval during TH, magnesium levels, and neurologic outcomes. Methods: We reviewed the electrocardiograms of 366 patients who underwent TH at various intervals corresponding to pre-cooling, maintenance of targeted temperature management, and rewarming periods. We reviewed the change in the corrected QT segment (QTc) and evaluated their relationship with the patients’ magnesium levels and neurologic outcomes. Results: 71.3% of the patients had a significant increase in QTc interval defined as >60 ms or any QTc>500 ms during TH. Patients with persistent prolongation of QTc after rewarming had poor neurological outcomes (p<0.05). Magnesium level showed a positive correlation with QTc interval at presentation (R=0.240, p<0.05) and at 48 hours (R=0.225, p= <0.05). Patients who had poor neurological outcomes tended to have higher magnesium levels at presentation (p<0.05). The majority of patients who received supplemental Mg did not have any significant change in their QTc. Conclusion: TH is independently associated with QTc prolongation. Patients with a persistent increase in QTc interval during the rewarming phase should be promptly evaluated for QTc-prolonging factors given its association with worse neurological outcomes. The inverse correlation between magnesium levels and poor neurological outcomes deserves further investigation.